Hormel Recalls Over 256,000 Pounds of Canned Beef Stew Due to Contamination Concerns

Hormel Foods has recalled over 256,000 pounds of canned beef stew due to reports of wood fragments in the product. Consumers are advised to dispose of or return affected cans to prevent potential health risks.
Hormel Foods has initiated a nationwide recall of more than 256,000 pounds of its popular Dinty Moore Beef Stew following reports that some cans contain wood fragments. The U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) announced the recall on May 28, 2025, after receiving consumer complaints about foreign objects in the product.
The affected product is packaged in 20-ounce cans labeled "Dinty Moore Beef Stew." These cans can be identified by the following details: a "Best by" date of February 2028, lot code T02045, and establishment number EST 199G. The recalled cans were distributed across retail stores nationwide.
The discovery of the contamination was made when the processing plant reported that three consumers had complained about finding wooden pieces inside the cans. No injuries or illnesses have been reported so far. However, consumers are advised to dispose of the product or return it to the place of purchase for a refund.
This incident marks a recurrence of wood fragment issues in food products in 2025, as earlier in the year, Nestlé recalled some of its Lean Cuisine and Stouffer's frozen meals due to similar concerns.
Consumers who experience any injury or health issues related to the product should contact a healthcare provider. The full recall notice is available on the FSIS website: https://www.fsis.usda.gov/recalls-alerts/hormel-foods-corporation-recalls-canned-beef-stew-product-due-possible-foreign. For more information, refer to the official source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Loss of Medicare Part D Assistance Associated with Increased Mortality in Low-Income Seniors
Losing Medicare Part D low-income assistance has been linked to higher death rates among older adults, highlighting the importance of maintaining Medicaid coverage for vulnerable seniors. Research shows that disruptions in prescription aid are associated with increased mortality, especially among those with complex health needs.
Emerging Evidence Indicates Survival Benefits of REM-Inhibition Therapy in ALS Patients
Emerging research suggests that pharmacological REM sleep inhibition may offer survival benefits for ALS patients, indicating a new direction in disease management and therapy development.
UK Investigates Genetic Factors Linking Obesity Medications and Pancreatitis Risk
The UK is investigating genetic factors that may increase the risk of pancreatitis in patients using obesity drugs like Wegovy and Zepbound. Authorities are calling for reports from affected individuals to better understand this potential genetic link and ensure patient safety.